http://venturebeat.com/2008/02/15/qa-with-mdvs-bill-ericson-on-pacbios-origin-why-gattaca-isnt-our-future-throwing-out-your-statins-and-more/ News About Tech, Money and Innovation Wed, 25 Nov 2009 05:28:47 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2008/02/15/qa-with-mdvs-bill-ericson-on-pacbios-origin-why-gattaca-isnt-our-future-throwing-out-your-statins-and-more/comment-page-1/#comment-800338 Life-science briefing: Wednesday, March 26, 2008 » VentureBeat Wed, 26 Mar 2008 20:43:26 +0000 http://venturebeat.com/2008/02/15/qa-with-mdvs-bill-ericson-on-pacbios-origin-why-gattaca-isnt-our-future-throwing-out-your-statins-and-more/#comment-800338 [...] $1,000 genome by the end of 2009. Don’t miss my Q&A with MDV’s Bill Ericson about the medical promise of fast, cheap genome scans. Tags: $100-genome, $1000-genome, co:BioNanomatrix, co:OptiMedica, deal, eye-disease, genomics, [...] [...] $1,000 genome by the end of 2009. Don’t miss my Q&A with MDV’s Bill Ericson about the medical promise of fast, cheap genome scans. Tags: $100-genome, $1000-genome, co:BioNanomatrix, co:OptiMedica, deal, eye-disease, genomics, [...]

]]> http://venturebeat.com/2008/02/15/qa-with-mdvs-bill-ericson-on-pacbios-origin-why-gattaca-isnt-our-future-throwing-out-your-statins-and-more/comment-page-1/#comment-795956 Anthony Kuhn Wed, 20 Feb 2008 21:33:08 +0000 http://venturebeat.com/2008/02/15/qa-with-mdvs-bill-ericson-on-pacbios-origin-why-gattaca-isnt-our-future-throwing-out-your-statins-and-more/#comment-795956 Welcome to a brave, new world of the genome economy. I wonder how long it will be until a person's sequence will be bought and sold on an open market? Interesting interview and also a thought-provoking one. I linked to this piece in my blog at the Innovators-Network, as such advances in are of interest to my audience. Welcome to a brave, new world of the genome economy. I wonder how long it will be until a person’s sequence will be bought and sold on an open market? Interesting interview and also a thought-provoking one. I linked to this piece in my blog at the Innovators-Network, as such advances in are of interest to my audience.

]]>